Cart
sales@molnova.com
Ataquimas
CAS No. 586348-21-2
Ataquimas( 2(1H)-Quinoxalinone,1-ethyl-3-(methylamino)-(9CI) )
Catalog No. M28931 CAS No. 586348-21-2
Ataquimast inhibits IL-5 secretion along with that of TNF-a, IL-4 and GM-CSF from human cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 101 | Get Quote |
|
| 10MG | 141 | Get Quote |
|
| 25MG | 234 | Get Quote |
|
| 50MG | 347 | Get Quote |
|
| 100MG | 517 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAtaquimas
-
NoteResearch use only, not for human use.
-
Brief DescriptionAtaquimast inhibits IL-5 secretion along with that of TNF-a, IL-4 and GM-CSF from human cells.
-
DescriptionAtaquimast inhibits IL-5 secretion along with that of TNF-a, IL-4 and GM-CSF from human cells.
-
In Vitro——
-
In Vivo——
-
Synonyms2(1H)-Quinoxalinone,1-ethyl-3-(methylamino)-(9CI)
-
PathwayOthers
-
TargetOther Targets
-
RecptorMRP1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number586348-21-2
-
Formula Weight203.24
-
Molecular FormulaC11H13N3O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCN(c(cccc1)c1N=C1NC)C1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Norman BH, et al. Cyclohexyl-linked tricyclic isoxazoles are potent and selective modulators of the multidrug resistance protein (MRP1). Bioorg Med Chem Lett. 2005 Dec 15;15(24):5526-30.
molnova catalog
related products
-
Triumbelletin
Triumbelletin is a tricoumarin rhamnopyranoside obtained from Wikstroemia indica with antitumour activity for the study of tumours.
-
Pomalidomide-PEG4-C-...
Pomalidomide-PEG4-C-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide-based cereblon ligand and 4-unit PEG linker used in PROTAC technology.
-
DTP3
DTP3 is a selective MKK7/GADD45β inhibitor, which inhibits cancer-selective NF-κB survival pathway.
